Interventional Cardiology & Surgery
Conference Coverage
TAVR now used in almost 50% of younger severe aortic stenosis patients
These findings have implications for lifetime management of younger patients who undergo TAVR.
Conference Coverage
In cardiogenic shock, edge-to-edge mitral valve repair improves outcome
Transcatheter edge-to-edge repairs were associated with lower mortality and hospitalization in an analysis of a large, international registry.
Conference Coverage
Fourth-gen transcatheter mitral valve shows clinical, procedural improvements
Abbott’s MitraClip G4 device showed the lowest all-cause mortality to date in for transcatheter mitral valve replacement in a postmarket study.
Conference Coverage
Extravascular ICD surpasses goals in pivotal trial
A novel “extravascular” ICD that avoids some limitations of prior ICD types surpassed its prespecified efficacy and safety goals in a pivotal...
Conference Coverage
Heparin pretreatment may safely open arteries before STEMI cath
The “early reperfusion” associated with IRA patency at angiography “could have long-term benefit due to smaller infarct size.”
Conference Coverage
PARADISE-MI results obscured as post hoc analysis finds flaws
A post hoc analysis of the PARADISE-MI trial suggests relevant benefits are being missed in current trial design.
Conference Coverage
No invasive strategy benefit at 5 years in ISCHEMIA-CKD extension study
The trial speaks to the lofty high-risk status of patients with CAD. ‘You’re seeing in a group of patients, with largely preserved EF but advanced...
Guidelines
ACC/AHA issue chest pain data standards update to 2021 guideline
The data standards are an effort to harmonize the language around chest pain and should be “broadly applicable,” the work group says.
Conference Coverage
Patisiran benefits ATTR amyloidosis with cardiomyopathy: APOLLO-B
More details of the positive results with the RNAi therapeutic on functional capacity and quality of life were reported.
News
FDA warns of clip lock malfunctions with MitraClip devices
Letters sent Sept. 8 by the FDA and Abbott Vascular, the device manufacturer, warn about an increase in reports that the device’s clip lock can...
From the Journals
Artificial sweeteners linked to higher CV event risk
The first study to include artificial sweetener from all sources, not just drinks, may increase concerns about these agents. But not all are...